Bank of New York Mellon
TMDX icon

Bank of New York Mellon’s Transmedics TMDX Stock Holding History

Bank of New York Mellon’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9M Sell
193,752
-17,616
-8% -$1.49M ﹤0.01% 1901
2026
Q1 		$21M Sell
211,368
-7,228
-3% -$943K ﹤0.01% 1514
2025
Q4 		$26.6M Buy
218,596
+6,799
+3% +$853K ﹤0.01% 1377
2025
Q3 		$23.8M Sell
211,797
-9,479
-4% -$1.11M ﹤0.01% 1453
2025
Q2 		$29.7M Buy
221,276
+11,599
+6% +$1.27M 0.01% 1301
2025
Q1 		$14.1M Sell
209,677
-143,585
-41% -$9.88M ﹤0.01% 1682
2024
Q4 		$22M Sell
353,262
-131,656
-27% -$12.3M ﹤0.01% 1510
2024
Q3 		$76.1M Buy
484,918
+64,191
+15% +$9.89M 0.01% 779
2024
Q2 		$63.4M Sell
420,727
-111,168
-21% -$13.3M 0.01% 887
2024
Q1 		$39.3M Sell
531,895
-155,130
-23% -$12.8M 0.01% 1183
2023
Q4 		$54.2M Sell
687,025
-73,074
-10% -$4.41M 0.01% 990
2023
Q3 		$41.6M Buy
760,099
+363,012
+91% +$26.1M 0.01% 1110
2023
Q2 		$33.3M Sell
397,087
-20,693
-5% -$1.58M 0.01% 1250
2023
Q1 		$31.6M Sell
417,780
-49,761
-11% -$3.44M 0.01% 1292
2022
Q4 		$28.9M Sell
467,541
-171,143
-27% -$9.1M 0.01% 1339
2022
Q3 		$26.7M Sell
638,684
-44,437
-7% -$1.93M 0.01% 1328
2022
Q2 		$21.5M Buy
683,121
+93,299
+16% +$2.49M ﹤0.01% 1495
2022
Q1 		$15.9M Sell
589,822
-46,069
-7% -$825K ﹤0.01% 1809
2021
Q4 		$12.2M Buy
635,891
+535,782
+535% +$13.4M ﹤0.01% 1994
2021
Q3 		$3.31M Buy
100,109
+24,827
+33% +$759K ﹤0.01% 2712
2021
Q2 		$2.5M Sell
75,282
-131,131
-64% -$3.63M ﹤0.01% 2854
2021
Q1 		$8.56M Buy
206,413
+3,616
+2% +$111K ﹤0.01% 2177
2020
Q4 		$4.04M Sell
202,797
-5,185
-2% -$76.7K ﹤0.01% 2457
2020
Q3 		$2.87M Buy
207,982
+130,904
+170% +$2.24M ﹤0.01% 2478
2020
Q2 		$1.38M Buy
77,078
+21,927
+40% +$343K ﹤0.01% 2912
2020
Q1 		$666K Buy
55,151
+17,927
+48% +$300K ﹤0.01% 3230
2019
Q4 		$708K Buy
37,224
+13,965
+60% +$256K ﹤0.01% 3402
2019
Q3 		$552K Buy
23,259
+10,076
+76% +$242K ﹤0.01% 3479
2019
Q2 		$382K Buy
+13,183
New +$360K ﹤0.01% 3726

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Bank of New York Mellon's TMDX Position: Q2 2026 in Review

Bank of New York Mellon reduced its Transmedics (TMDX) stake by 8.3% in Q2 2026, selling an estimated $1.49M and leaving 193,752 shares worth $12.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1901.

Bank of New York Mellon first reported a position in TMDX in Q2 2019 and has held it in 29 quarters since. The position peaked at $76.1M in Q3 2024. 238 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Bank of New York Mellon held 193,752 shares of Transmedics worth $12.9M as of Q2 2026.
  • Bank of New York Mellon sold 17,616 Transmedics shares in Q2 2026, an estimated $1.49M.
  • Transmedics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1901 holding.
  • Bank of New York Mellon first reported a position in Transmedics in Q2 2019 and has held it in 29 quarters since.
  • Bank of New York Mellon's Transmedics position peaked at $76.1M in Q3 2024.
  • 238 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.